The FDA has issued a second complete response letter to Atara Biotherapeutics for its biologicals license application of ...
A middle-aged woman with a 6-year history of stable inflammatory bowel disease (IBD) presented with progressively worsening abdominal pain, increased stool frequency and rectal bleeding. Colonoscopy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback